Connect to other sites within the UBM Medica Network
Weight Loss Improves Atrial Fibrillation, Cardiometabolic Profile
Results of the LEGACY study show long-term weight loss decreases AF burden and supports sustained sinus rhythm. A short slide show summarizes the 2015 ACC late-breaking abstract.
Oral Anticoagulation: Would You Recognize a Candidate?
What does the patient with atrial fibrillation who would benefit from oral anticoagulation look like today? Q & A, here.
Atrial Fibrillation: More Than an Electrical Problem
A small study highlights a big point: manage risk factors that affect the atrial fibrillation substrate and ablation therapy success rates improve (ARREST-AF Cohort Study).
Primary Care Quiz: CHA2DS2-VASc Stroke Risk Calculator
What is your command of the components of this risk prediction tool for patients with atrial fibrillation? Find out with our 4-question quiz.
Top 5 Things to Remember About Rhythm Control in AF
When is a rhythm control strategy appropriate? Which patients are candidates for amiodarone? When is AF ablation the answer? Here, a top-line review of rhythm control for atrial fibrillation.
Game Change in the World of Atrial Fibrillation
The absence of an antidote may soon disappear as a reason to avoid prescribing a novel oral anticoagulant to patients with atrial fibrillation, based on promising phase III trial results.
Dabigatran Increases “Real-World” Bleeding
The risk for major bleeding and GI hemorrhage in patients taking dabigatran was greater than in those taking warfarin; warfarin, however, was associated with a greater risk of intracranial hemorrhage.
By clicking Accept, you agree to become a member of the UBM Medica Community.